BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19095449)

  • 1. Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones.
    Ma X; Zhou W; Brun R
    Bioorg Med Chem Lett; 2009 Feb; 19(3):986-9. PubMed ID: 19095449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.
    Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ
    Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.
    Keenan M; Abbott MJ; Alexander PW; Armstrong T; Best WM; Berven B; Botero A; Chaplin JH; Charman SA; Chatelain E; von Geldern TW; Kerfoot M; Khong A; Nguyen T; McManus JD; Morizzi J; Ryan E; Scandale I; Thompson RA; Wang SZ; White KL
    J Med Chem; 2012 May; 55(9):4189-204. PubMed ID: 22536986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms.
    Becerra MC; Guiñazú N; Hergert LY; Pellegrini A; Mazzieri MR; Gea S; Albesa I
    Exp Parasitol; 2012 May; 131(1):57-62. PubMed ID: 22425748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents.
    Suto Y; Nakajima-Shimada J; Yamagiwa N; Onizuka Y; Iwasaki G
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2967-71. PubMed ID: 26037321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,2,3-Triazole-based analogue of benznidazole displays remarkable activity against Trypanosoma cruzi.
    de Andrade P; Galo OA; Carvalho MR; Lopes CD; Carneiro ZA; Sesti-Costa R; de Melo EB; Silva JS; Carvalho I
    Bioorg Med Chem; 2015 Nov; 23(21):6815-26. PubMed ID: 26476667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole.
    Honorato SB; Mendonça JS; Boechat N; Oliveira AC; Mendes Filho J; Ellena J; Ayala AP
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():389-94. PubMed ID: 24076454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, physicochemical properties of allopurinol derivatives and their biological activity against Trypanosoma cruzi.
    Raviolo MA; Solana ME; Novoa MM; Gualdesi MS; Alba-Soto CD; Briñón MC
    Eur J Med Chem; 2013 Nov; 69():455-64. PubMed ID: 24090917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-Trypanosoma cruzi activity of diaryldiazepines.
    Menezes JC; Vaz LB; de Abreu Vieira PM; da Silva Fonseca K; Carneiro CM; Taylor JG
    Molecules; 2014 Dec; 20(1):43-51. PubMed ID: 25546620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro investigation of the efficacy of novel diamidines against Trypanosoma cruzi.
    Timm BL; Da Silva PB; Batista MM; Farahat AA; Kumar A; Boykin DW; Soeiro MN
    Parasitology; 2014 Sep; 141(10):1272-6. PubMed ID: 24735493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular design, synthesis and biological evaluation of 1,4-dihydro-4-oxoquinoline ribonucleosides as TcGAPDH inhibitors with trypanocidal activity.
    Soares FA; Sesti-Costa R; da Silva JS; de Souza MC; Ferreira VF; Santos Fda C; Monteiro PA; Leitão A; Montanari CA
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4597-601. PubMed ID: 23850203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
    Duschak VG
    Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Kaiser M
    Eur J Med Chem; 2014 Nov; 87():79-88. PubMed ID: 25240098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective activity of 2,4-diaryl-1,2,3,4-tetrahydroquinolines on Trypanosoma cruzi epimastigotes and amastigotes expressing β-galactosidase.
    Fonseca-Berzal C; Merchán Arenas DR; Romero Bohórquez AR; Escario JA; Kouznetsov VV; Gómez-Barrio A
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4851-6. PubMed ID: 23899616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.
    Soares FGN; Göethel G; Kagami LP; das Neves GM; Sauer E; Birriel E; Varela J; Gonçalves IL; Von Poser G; González M; Kawano DF; Paula FR; de Melo EB; Garcia SC; Cerecetto H; Eifler-Lima VL
    BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):76. PubMed ID: 31852548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Synthesis of Waltherione F and Its Analogues with Modifications at the 2- and 3-Positions as Potential Antitrypanosomal Agents.
    Zdorichenko V; Paumier R; Whitmarsh-Everiss T; Roe M; Cox B
    Chemistry; 2019 Jan; 25(5):1286-1292. PubMed ID: 30398681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antiparasitic activity of new thiosemicarbazones in strains of Trypanosoma cruzi.
    Moreno-Rodríguez A; Salazar-Schettino PM; Bautista JL; Hernández-Luis F; Torrens H; Guevara-Gómez Y; Pina-Canseco S; Torres MB; Cabrera-Bravo M; Martinez CM; Pérez-Campos E
    Eur J Med Chem; 2014 Nov; 87():23-9. PubMed ID: 25238291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease.
    Rodrigues GC; Feijó DF; Bozza MT; Pan P; Vullo D; Parkkila S; Supuran CT; Capasso C; Aguiar AP; Vermelho AB
    J Med Chem; 2014 Jan; 57(2):298-308. PubMed ID: 24299463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of benzoylisoquinolines as potential anti-Chagas agents.
    Byler KG; Brito-Arias M; Marquez-Navarro A; Nogueda-Torres B; Torres-Bustillos LG; Martínez-Mayorga K
    Bioorg Med Chem; 2012 Apr; 20(8):2587-94. PubMed ID: 22436391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and antitrypanosomal activity of secochiliolide acid derivatives.
    Siless GE; Lozano E; Sánchez M; Mazzuca M; Sosa MA; Palermo JA
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4964-7. PubMed ID: 23910983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.